$ALTO

Alto Ingredients, Inc. (ALTO): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Alto Ingredients, Inc. (ALTO) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. EX-10.1 2 ea029568801ex10-1.htm ALTO INGREDIENTS, INC. 2026 OMNIBUS INCENTIVE PLAN Exhibit 10.1 ALTO INGREDIENTS, INC. 2026 OMNIBUS INCENTIVE PLAN ALTO INGREDIENTS, INC., a Delaware corporation, sets forth herein the terms of its 2026 Omnibus Incentive Plan, as follows: 1. PURPOS

Original reporting
Published Jun 23, 2026, 8:18 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 23, 2026, 8:21 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$ALTO
Neutral
medium confidence
Mentioned
$ALTO
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$ALTONeutralLow
01

Why it matters

Establishing an omnibus incentive plan can influence future equity compensation and potential dilution, but the provided excerpt does not include grant quantities, award terms beyond general structure, or named officer/director changes.

02

Market read

This is a governance/compensation disclosure with likely limited immediate trading impact absent quantified dilution or specific executive/director changes.

03

What to watch

Traders should check the full 8-K for the actual director/officer changes (Item 5.02) and any specific award grants or share-count/dilution estimates, which are not present in the provided text.

Relevance 6/10Novelty 3/10Timing: post-close filing (8-K filed 2026-06-23 16:18 ET)

Background

The SEC 8-K (Item 5.02) reports director/officer matters and includes Exhibit 10.1 detailing ALTO’s 2026 Omnibus Incentive Plan, approved by stockholders with an effective date of June 23, 2026.

Company-level read

Ticker impact

$ALTONeutralMedium confidence
Context

ALTO filed an 8-K for Item 5.02 and attached its 2026 Omnibus Incentive Plan terms, effective June 23, 2026.

Expected impact

Likely limited immediate price impact; any effect would be indirect via dilution/compensation optics rather than a discrete earnings or deal catalyst.

Evidence & confidence

The excerpt mainly contains plan boilerplate and definitions, with no disclosed grant amounts, director/officer names, or quantified compensation changes beyond establishing the plan and its effective date.

Market effects

Compensation-plan updates are common in small/mid-cap industrial/ingredient companies; read-through is mainly dilution/retention optics rather than sector fundamentals.

None indicated.

None indicated.

Counterpoint

Because the excerpt is largely plan boilerplate, the market may already price the existence of an incentive plan; any reaction could be noise unless specific grants/dilution are disclosed elsewhere in the full 8-K.

Key entities

  • Alto Ingredients, Inc.

    Subject of the SEC 8-K; filed Item 5.02 and attached the 2026 Omnibus Incentive Plan (Exhibit 10.1).

  • 2026 Omnibus Incentive Plan

    Equity compensation framework for options, SARs, restricted stock/RSUs, and other stock-based awards; effective June 23, 2026.

Related articles

$ALTOMedAI 9/10

Alto (ALTO) Q2 2026 Earnings Call Transcript

Alto Ingredients (ALTO) reported Q2 2026 results in an earnings call. Net sales rose to $245.7M, adjusted EBITDA was $23.7M, and net income attributable to common stockholders was $11.4M ($0.15/diluted share). Full-year Section 45Z guidance is $15M to $16M. Management discussed capacity expansion, CO2 storage, and a $50M at-the-market equity program.

$ALTOMed

Alto Ingredients, Inc. (ALTO): Results of Operations and Financial Condition

Alto Ingredients, Inc. (ALTO) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Alto Ingredients, Inc. Reports Second Quarter 2026 Results Q2 2026 Gross Profit of $16.6 Million Increased $18.6 Million Q2 2026 Net Income of $11.4 Million, or $0.15 per Share, Improved $22.7 Million Q2 2026 Adjusted EBITDA of $23.7 Million Improved $23.9 Million Pe

$BAHighAI 9/10

Air Force awards Boeing $131 billion ceiling contract for F-15 production, modernization

The U.S. Air Force awarded Boeing a $131.23 billion contract for F-15 production, modernization, and sustainment through 2037. The contract includes options for foreign military sales to several countries. Initial funding is $343,740 for fiscal 2026. Boeing will perform the work in St. Louis. The contract does not guarantee full spending and includes no immediate jet orders.

$AECMed

SW US: Anfield wants $50M for Utah mill

Anfield Energy (TSXV, Nasdaq: AEC) plans to raise $50M to refurbish Utah's Shootaring Canyon mill, aiming for a 2028 reopening. The mill will process uranium and vanadium, reducing U.S. reliance on imports. Capital expenditures are estimated at $80.1M, with flexibility in financing options. The company expects a mill licence by late 2024 or early 2027, unlocking financing and construction. An updated PEA forecasts significant after-tax NPV and IRR, with production from Velvet-Wood and Slick Rock